Abstract
Thymomas and thymic carcinomas are relatively rare tumours, some of them are often accompanied by autoimmune diseases. Article deals with epidemiology, diagnosis, classification, therapy and dispensarisation of epithelial thymic tumours based on contemporary ESMO guidelines1 and own 38 years experience.